US Pharma MarketingThe post Bayesian Health secures first FDA clearance for AI-driven continuous sepsis monitor appeared first on Medical Device Network.
Bayesian Health secures first FDA clearance for AI-driven continuous sepsis monitor
Bayesian's AI-driven device is the first of its kind to get the FDA's clearance for early sepsis detection. The device is the first of its kind to get the FDA greenlight to allow for early sepsis detection. Bayesian says it is the first company to secure FDA 510(k) clearance for a AI-powered continuous monitoring device for sepsis. Credit: AnaLysiSStudiO / Shutterstock.com. The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to achieve this milestone. The solution, which represents a segment of Bayesian’s real-time clinical…
Bayesian's AI-driven device is the first of its kind to get the FDA's clearance for early sepsis detection.
Source: Medical Device Network